The global Continuous renal replacement therapy therapy market size is projected to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 8.1% during the forecast period.
Various factors such as increasing incidences of Acute kidney injyury (AKI) and rising prominence on effective renal replacement therapy among patients in ICU and critically ill patients are majorly attributing to the rise in the demand for CRRT system and disposables. Moreover, the technologically advanced CRRT system in the market and rising prevalence of hypertension and rising cases of Acute kidney injury, are some of the factors which are anticipated to drive the demand for Continuous renal replacement therapy therapy during the forecast period.
“The dialysate and replacement fluid segment to capture the largest share in Continuous renal replacement therapy therapy market, by product, during the forecast period.”
The dialysate and replacement fluid segment is expected to witness the high growth rate during the forecast period. The high growth owes to the significant increase in the demand for CRRT in the treatment for the patients who are unstablehemodynamically , the increase in the number of manufacturers who are offering dialysate and replacement fluids for renal replacement therapy, and also the strong presence of players in the market.
“The continuous venovenous hemodiafiltration segment to witness highest growth rate in Continuous renal replacement therapy therapy market, by modality in 2022.”
The continuous venovenous hemodiafiltration modality segment is expected to witness the highest growth rate in the CRRT market during the forecast period. The rising preference of continuous venovenous hemodiafiltrationmodality among nephrologists and critical care physicians, and also the advantages which includes better clearance of medium-sized solutes in comparison to hemodialysis (accurate acid-base balance without intervention, and a significant reduction in CRRT-related phosphate depletion area are some of the factors which supports the growth of the segment in the coming years.
“The Hospital segment accounted for the largest share of the Continuous renal replacement therapy therapy, by age group, in 2022”
The CRRT process mainly adopted in hospitals due to its technological advancements and cost of investment. The economical stability of hospitals among other end users has led to its larger market share. The continuous renal replacement therapy (CRRT) is mostly used treatment in hospitals, especially in the intensive care unit (ICU) or the patients who are critically ill. It can help to stabilize hemodynamic parameters and improve clinical symptoms and organ function in patients, which can help to reduce complications
“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The Continuous renal replacementtherapy market is segmented into five major regions, , North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The increase in the awareness of Continuous renal replacement therapy therapy, increasing healthcare expenditures, rising of the disposable incomes , rising incidences of sepsis, increasing prevalence of hypertension & diabetes (major causes of AKI), the high use of CRRT in Australia and Japan, , and increasing accessibility to CRRT for AKI treatment are some of the key factors that are playing major role in increase of adoption of the CRRT systems in Asia Pacific region
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
- By Designation: C-level: 26%, D-level: 30%, and Others: 44%
- By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%
The major players operating in the Continuous renal replacement therapy therapy market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), and B. Braun Melsungen AG (Germany),
Research Coverage
This report studies the Continuous renal replacement therapy therapy market based on the product, modality, age group, end users and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Key Benefits of Buying the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below-mentioned five strategies.
This report provides insights into the following pointers:
- Market Driver: The growth of the market attributes to increase of advanced technology and benefits of using CRRT systems.
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Continuous renal replacement therapy market. The report analyzes the market based on the product, modality, age group, end users and region.
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the Continuous renal replacement therapy market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for Continuous renal replacement therapy across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the Continuous renal replacement therapy market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the Continuous renal replacement therapy market